French President Francois Hollande said Paris has seen indications of a new chemical-arms attack against the Syrian opposition, the London Guardian reports.
Hollande on Sunday did not elaborate on what “information” his government holds, and he stressed that the data was not conclusive. Opponents of Syrian President Bashar Assad’s government have described nine possible incidents of chemical-weapons use over the last two months in the country’s civil war.
The apparent strikes were “much less significant than those in Damascus … but very deadly,” Hollande told the European broadcaster Radio 1.
The claims, which came from anti-Assad groups both outside of Syria and in the nation’s western and southern regions, linked the possible strikes to at least 10 deaths and additional injuries in the hundreds. Assad’s government agreed to surrender its chemical-warfare stockpile last year, after sarin nerve agent in August killed hundreds of people in an opposition-controlled suburb of the Syrian capital.
Still, the regime has denied responsibility for any chemical strikes. On Saturday, Iran’s Fars News Agency accused rebels of carrying out chlorine-gas attacks in the Syrian city of Homs.
The Organization for the Prohibition of Chemical Weapons, which is helping to monitor the dismantlement of Assad’s arsenal, has said it would not review new allegations of Syrian chemical-arms use without a member country’s request.
The watchdog agency on Sunday said ships have removed roughly four-fifths of Assad’s chemical stockpile from Syria. The latest shipments would “contribute” to efforts to fully destroy the materials by the end of June, according to an OPCW statement.
Sigrid Kaag, the special coordinator of a U.N.-OPCW oversight operation, in Saturday comments said “the renewed pace in movements is positive and necessary to ensure progress towards a tight deadline.”
International authorities said Assad’s government has finished eliminating unfilled mustard-agent shells, and has taken steps to shutter sites for manufacturing and holding warfare chemicals.
What We're Following See More »
A new Investor’s Business Daily/TechnoMetrica Market Intelligence poll shows Hillary Clinton and Donald Trump each earning 41% support. On the one hand, the poll has been skewing in Trump's favor this year, relative to other polls. But on the other, data guru Nate Silver called the IBD/TIPP poll the most accurate in 2012.
"Sen. Bernie Sanders, a loyal soldier for Hillary Clinton since he conceded the Democratic presidential nomination in July, plans to push liberal legislation with like-minded senators with or without Clinton’s support if she is elected— and to aggressively oppose appointments that do not pass muster with the party’s left wing." Sanders and other similarly inclined senators are already "plotting legislation" on climate change, prison reform, the minimum wage, and tuition-free college.
"The political organization of Virginia Gov. Terry McAuliffe, an influential Democrat with longstanding ties to Bill and Hillary Clinton, gave nearly $500,000 to the election campaign of the wife of an official at the Federal Bureau of Investigation who later helped oversee the investigation into Mrs. Clinton’s email use."
Baseball great Curt Schilling says he still needs to clear a challenge to Sen. Elizabeth Warren with his wife, but in the meantime, he's found something to occupy him: the former hurler is going to host a daily online radio show on Breitbart.com. "The show marks Schilling’s return to media six months after ESPN fired him for sharing an anti-transgender Facebook post."
The New Yorker has endorsed Hillary Clinton, saying that "barring some astonishment," she will become the next president. Calling Clinton "distinctly capable," the magazine excoriates Donald Trump as a candidate who "favors conspiracy theory and fantasy, deriving his knowledge from the darker recesses of the Internet and 'the shows.'" Additionally, the historical nature of the possibility of "send[ing] a woman to the White House" is not lost on the editors, who note the possibility more than once in the endorsement.